Look for Patients on Esketamine or Ketamine for Depression

June 2025

We’re getting questions about the role of Rx nasal esketamine (Spravato) or IV ketamine for treatment-resistant depression.

Esketamine nasal spray was first approved for use in COMBO with an oral antidepressant (escitalopram, etc) for hard-to-treat depression.

Now, it can also be used on its own as monotherapy.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

New Drugs Watch for New Twists to Older Medications
Immunizations Help Address Vaccine Hesitancy
Practice Be Aware of New Technician Certification Exam Changes
Vaginal Infections Expect Some Males to Get Antibiotics for Bacterial Vaginosis
Pediatrics Stay Alert for Mishaps With Pain Meds in Kids
Hazardous Meds Focus on Hazardous Med Safety with USP 800
Depression Look for Patients on Esketamine or Ketamine for Depression
NatMed Spotlight Know Answers About Cordyceps or “Caterpillar Fungus”